13F History
Schedule 13D/G History
Other Reports

Avidity Partners Management LP - Significant Ownership

Signature - Title: Delmer Dee Raibourn III - Chief Compliance Officer
Location: Dallas, TX
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Avidity Partners Management LP.

Significant Ownership of Avidity Partners Management LP

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
DNTH	Dianthus Therapeutics, Inc. /DE/	Common Stock, $0.001 par value	9.9%	$71.9M		3.38M		Avidity Partners Management LP	Mar 17, 2025
IMUX	IMMUNIC, INC.	Common Stock, par value $0.0001	9.9%	$10.1M		9.02M		Avidity Partners Management LP	Dec 31, 2024
CNTX	Context Therapeutics Inc.	$0.001 par value per share	9.9%	$5.05M		7.78M		Avidity Private Master Fund I LP	Dec 31, 2024
SCYX	SCYNEXIS INC	Common Stock, par value $0.001 per share	9.9%	$3.62M		4.21M		Avidity Master Fund LP	Dec 31, 2024
SYRS	Syros Pharmaceuticals, Inc.	Common Stock, $0.001 par value	7.6%	$164K		2.05M		Avidity Partners Management LP	Dec 31, 2024
KZR	Kezar Life Sciences, Inc.	Common Stock, par value $0.001 per share	6.9%	$397K		503K		Avidity Partners Management LP	Dec 31, 2024
CATX	Perspective Therapeutics, Inc.	Common Stock, $0.001 par value	4.2%	$7.56M		2.84M		Avidity Partners Management LP	Dec 31, 2024

Showing 1 to 7 of 7 entries

Schedules 13D/G Reported by Avidity Partners Management LP:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Date Filed
DNTH	Dianthus Therapeutics, Inc. /DE/	Common Stock, $0.001 par value	9.9%		3.38M		$71.9M	Avidity Partners Management LP	13D/A	3/17/2025	3/19/2025
KZR	Kezar Life Sciences, Inc.	Common Stock, par value $0.001 per share	6.9%		503K		$397K	Avidity Partners Management LP	13G/A	12/31/2024	2/14/2025
CATX	Perspective Therapeutics, Inc.	Common Stock, $0.001 par value	4.2%		2.84M		$7.56M	Avidity Partners Management LP	13G/A	12/31/2024	2/14/2025
SCYX	SCYNEXIS INC	Common Stock, par value $0.001 per share	9.9%		4.21M		$3.62M	Avidity Master Fund LP	13G/A	12/31/2024	2/14/2025
IMUX	IMMUNIC, INC.	Common Stock, par value $0.0001	9.9%		9.02M		$10.1M	Avidity Partners Management LP	13G/A	12/31/2024	2/14/2025
SYRS	Syros Pharmaceuticals, Inc.	Common Stock, $0.001 par value	7.6%		2.05M		$164K	Avidity Partners Management LP	13G/A	12/31/2024	2/14/2025
CNTX	Context Therapeutics Inc.	$0.001 par value per share	9.9%		7.78M		$5.05M	Avidity Private Master Fund I LP	13G/A	12/31/2024	2/14/2025

Showing 1 to 7 of 7 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.